Cholera Vaccines Companies, Corporate Milestones, Corporate Growth and Development Strategy, Mergers and Acquisitions (M&A)

Cholera Vaccines Companies and Competitive Landscape

The global cholera vaccines market size is calculated at USD 94.5 million in 2024, grew to USD 103.99 million in 2025, and is projected to reach around USD 246 million by 2034. The market is expanding at a CAGR of 10.04% between 2024 and 2034.

Top Companies in the Cholera Vaccines

• Bavarian Nordic A/S
• Bharat Biotech
• Biological E.
• Celldex Therapeutics
• EuBiologics
• GlaxoSmithKline
• Hilleman Laboratories
• Pfizer
• Sanofi S.A.
• Shanghai United Cell Biotechnology Co. Ltd.
• Shantha Biotechnics
• Valneva Sweden AB

Recent Developments in the Cholera Vaccines Market

• In August 2024, Bharat Biotech announced the launch of its new oral cholera vaccine, Hillchol, after achieving positive results from phase 3 trials. Hillchol was developed under the license from Singapore-based Hilleman Laboratories and will produce the vaccine with a capacity of 200 million doses.
• In April 2024, the WHO approved the pre-qualification of a novel cholera vaccine, Euvichol-S, developed by EuBiologics in collaboration with the Bill and Melinda Gates Foundation. Euvichol-S is a simplified formulation of Euvichol-Plus, reducing the number of vaccine components.

Sample U.S. Shipment Data for Cholera Vaccines and Related Products